International Journal of Antimicrobial Agents
Volume 35, Issue 5 , Pages 457-460 , May 2010

Antimicrobial susceptibility of Neisseria gonorrhoeae isolates determined by the agar dilution, disk diffusion and Etest methods: comparison of results using GC agar and chocolate agar

  • Chun-Hsing Liao

      Affiliations

    • Department of Infectious Disease, Far Eastern Memorial Hospital, Taipei, Taiwan
    • ,
  • Chih-Cheng Lai

      Affiliations

    • Department of Internal Medicine, Yi-Min Hospital, Taipei, Taiwan
    • ,
  • Meng-Shuian Hsu

      Affiliations

    • Department of Infectious Disease, Far Eastern Memorial Hospital, Taipei, Taiwan
    • ,
  • Fang-Yeh Chu

      Affiliations

    • Department of Clinical Pathology, Far Eastern Memorial Hospital, Taipei, Taiwan
    • ,
  • Mei-Yu Wu

      Affiliations

    • Department of Infectious Disease, Far Eastern Memorial Hospital, Taipei, Taiwan
    • ,
  • Yu-Tsung Huang

      Affiliations

    • Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan
    • Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan
    • ,
  • Po-Ren Hsueh

      Affiliations

    • Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan
    • Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan
    • Corresponding Author InformationCorresponding author. Tel.: +886 2 2312 3456x65355; fax: +886 2 2322 4263.

Received 23 November 2009 ,Accepted 5 January 2010.

References 

  1. Janda WM, Knapp JS. Neisseria and Moraxella catarrhalis. In:  Murray PR,  Baron EJ,  Jorgensen JH,  Pfaller MA,  Yolkden RH editor. Manual of clinical microbiology. 8th ed.. Washington, DC: American Society for Microbiology; 2003;p. 472–501
  2. Centers for Disease Control, R.O.C. (Taiwan). http://www.cdc.gov.tw [accessed 13 August 2007].
  3. Chu ML, Ho LJ, Lin HC, Wu YC. Epidemiology of penicillin-resistant Neisseria gonorrhoeae isolated in Taiwan, 1960–1990. Clin Infect Dis. 1992;14:450–457
  4. Tapsall JW. Antibiotic resistance in Neisseria gonorrhoeae. Clin Infect Dis. 2005;41(Suppl. 4):S263–S268
  5. Centers for Disease Control and Prevention (CDC). Increases in fluoroquinolone-resistant Neisseria gonorrhoeae—Hawaii and California, 2001. MMWR Morb Mortal Wkly Rep 2002; 51:1041–4.
  6. Knapp JS, Fox KK, Trees DL, Whittington WL. Fluoroquinolone resistance in Neisseria gonorrhoeae. Emerg Infect Dis. 1997;3:33–39
  7. Hsueh PR, Tseng SP, Teng LJ, Ho SW. High prevalence of ciprofloxacin-resistant Neisseria gonorrhoeae in Northern Taiwan. Clin Infect Dis. 2005;40:188–192
  8. Wang SA, Harvey AB, Conner SM, Zaidi AA, Knapp JS, Whittington WL, et al. Antimicrobial resistance for Neisseria gonorrhoeae in the United States, 1988 to 2003: the spread of fluoroquinolone resistance. Ann Intern Med. 2007;147:81–88
  9. Martin IM, Hoffmann S, Ison CA ESSTI Network. European Surveillance of Sexually Transmitted Infections (ESSTI): the first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe. J Antimicrob Chemother. 2006;58:587–593
  10. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard. 7th ed. Document M7-A7. Wayne, PA: CLSI; 2006.
  11. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests: approved standard. 9th ed. Document M2-A9. Wayne, PA: CLSI; 2006.
  12. Jones RN, Gavan TL, Thornsberry C, Fuchs PC, Gerlach EH, Knapp JS, et al. Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline. J Clin Microbiol. 1989;27:2758–2766
  13. Jones RN, Fuchs PC, Washington JA, Gavan TL, Murray PR, Gerlach EH, et al. Interpretive criteria, quality control guidelines, and drug stability studies for susceptibility testing of cefotaxime, cefoxitin, ceftazidime, and cefuroxime against Neisseria gonorrhoeae. Diagn Microbiol Infect Dis. 1990;13:499–507
  14. Ison CA, Martin IM, Lowndes CM, Fenton KA ESSTI Network. Comparability of laboratory diagnosis and antimicrobial susceptibility testing of Neisseria gonorrhoeae from reference laboratories in Western Europe. J Antimicrob Chemother. 2006;58:580–586
  15. World Health Organization. Laboratory diagnosis of gonorrhoea. WHO Regional Publication, South-East Asia Series No. 33. Geneva, Switzerland: WHO; 1999.
  16. Shapiro MA, Heifetz CL, Sesnie JC. Comparison of microdilution and agar dilution procedures for testing antibiotic susceptibility of Neisseria gonorrhoeae. J Clin Microbiol. 1984;20:828–830
  17. Clinical and Laboratory Standards Institute. Development of in vitro susceptibility testing criteria and quality control parameters; approved guideline. 2nd ed. Document M23-A2. Wayne, PA: CLSI; 2001.
  18. Woodford N, Ison CA. The effect of media on antimicrobial susceptibility testing of Neisseria gonorrhoeae. J Antimicrob Chemother. 1988;22:463–471
  19. Su X, Jiang F, Qimuge , Dai X, Sun H, Ye S. Surveillance of antimicrobial susceptibilities in Neisseria gonorrhoeae in Nanjing, China, 1999–2006. Sex Transm Dis. 2007;34:995–999
  20. Bala M, Ray K, Gupta SM, Muralidhar S, Jain RK. Changing trends of antimicrobial susceptibility patterns of Neisseria gonorrhoeae in India and the emergence of ceftriaxone less susceptible N. gonorrhoeae strains. J Antimicrob Chemother. 2007;60:582–586
  21. Yokoi S, Deguchi T, Ozawa T, Yasuda M, Ito S, Kubota Y, et al. Threat to cefixime treatment for gonorrhea. Emerg Infect Dis. 2007;13:1275–1277
  22. Wong WW, Huang CT, Li LH, Chiang CC, Chen BD, Li SY. Molecular epidemiological identification of Neisseria gonorrhoeae clonal clusters with distinct susceptibility profiles associated with specific groups at high risk of contracting human immunodeficiency virus and syphilis. J Clin Microbiol. 2008;46:3931–3934
  23. Biedenbach DJ, Jones RN. Comparative assessment of Etest for testing susceptibilities of Neisseria gonorrhoeae to penicillin, tetracycline, ceftriaxone, cefotaxime, and ciprofloxacin: investigation using 510(k) review criteria, recommended by the Food and Drug Administration. J Clin Microbiol. 1996;34:3214–3217

PII: S0924-8579(10)00040-3

doi: 10.1016/j.ijantimicag.2010.01.007

International Journal of Antimicrobial Agents
Volume 35, Issue 5 , Pages 457-460 , May 2010

Article Tools